DOI QR코드

DOI QR Code

Catecholaminergic Polymorphic Ventricular Tachycardia in a Patient With Recurrent Exertional Syncope

  • Kim, Na-Young (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Kang, Jung-Kyu (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Park, Sun-Hee (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Bae, Myung-Hwan (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Lee, Jang-Hoon (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Yang, Dong-Heon (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Park, Hun-Sik (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Chae, Shung-Chull (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Jun, Jae-Eun (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Cho, Yong-Keun (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • 발행 : 2012.02.29

초록

A 16-year-old male with a prior history of recurrent syncope was referred to our hospital after being resuscitated from cardiac arrest developed while playing volleyball. His electrocardiogram (ECG) demonstrated ventricular fibrillation at a local emergency department. After referral, an ECG showed bidirectional ventricular tachycardia (VT) and nonsustained Torsade de Pointes. Two days later, his heart rate became regular, and no additional episodes of VT were observed. His ECG showed sinus rhythm with a corrected QT interval of 423 msec, and two-dimensional echocardiography was unremarkable. We made the diagnosis of a catecholaminergic polymorphic VT. However, only premature ventricular complex bigeminy was induced on exercise ECG and epinephrine infusion tests, and the patient showed no episodes of syncope. His father and mother had different missense mutations in the cardiac ryanodine receptor on genetic testing. The proband had both mutations in different alleles and was symptomatic. It was recommended that the patient avoid competitive physical activities, and a ${\beta}$-blocker was prescribed.

키워드

참고문헌

  1. Horner JM, Ackerman MJ. Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm 2008;5:1690-4. https://doi.org/10.1016/j.hrthm.2008.08.038
  2. Krahn AD, Healey JS, Chauhan V, et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Circulation 2009;120: 278-85. https://doi.org/10.1161/CIRCULATIONAHA.109.853143
  3. George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003;93:531-40. https://doi.org/10.1161/01.RES.0000091335.07574.86
  4. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74. https://doi.org/10.1161/01.CIR.0000020013.73106.D8
  5. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-7. https://doi.org/10.1161/01.CIR.103.23.2822
  6. Nam GB, Burashnikov A, Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation 2005;111:2727-33. https://doi.org/10.1161/CIRCULATIONAHA.104.479295
  7. di Barletta MR, Viatchenko-Karpinski S, Nori A, et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006;114:1012-9. https://doi.org/10.1161/CIRCULATIONAHA.106.623793
  8. Maron BJ, Chaitmann BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109; 2807-16. https://doi.org/10.1161/01.CIR.0000128363.85581.E1
  9. Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119:2426-34. https://doi.org/10.1161/CIRCULATIONAHA.108.829267
  10. Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42:863-70. https://doi.org/10.1136/jmg.2004.028993
  11. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995;91:1512-9. https://doi.org/10.1161/01.CIR.91.5.1512
  12. Watanabe H, Chopra N, Laver D, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-3. https://doi.org/10.1038/nm.1942
  13. Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008;358:2024-9. https://doi.org/10.1056/NEJMoa0708006